Quarterly Results (Unaudited) (Tables)

12 Months Ended

Mar. 31, 2016

Quarterly Financial Information Disclosure [Abstract]

The following table presents the Company's selected unaudited quarterly operating results for the eight quarters ended March 31, 2016. The Company believes that all adjustments of a normal recurring nature have been made to present fairly the related quarterly results (in thousands, except per share amounts):



Fiscal 2016	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Total
Net sales	$	533,952	$	541,391	$	540,344	$	557,647	$	2,173,334
Gross profit	309,017		300,950		292,718		302,779		1,205,464
Operating income	121,319		74,948		76,132		79,946		352,345
Net income	130,460		64,899		61,211		67,355		323,925
Less: Net loss attributable to noncontrolling interests	207		—		—		—		207
Net income attributable to Microchip Technology	130,667		64,899		61,211		67,355		324,132
Diluted net income per common share attributable to Microchip Technology stockholders	0.60		0.30		0.28		0.31		1.49

Fiscal 2015	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Total
Net sales	$	528,876	$	546,243	$	528,710	$	543,207	$	2,147,036
Gross profit	306,519		307,454		301,959		313,632		1,229,564
Operating income	115,946		101,318		98,009		110,347		425,620
Net income	89,909		92,038		84,798		98,580		365,325
Less: Net loss attributable to noncontrolling interests	—		1,603		1,259		822		3,684
Net income attributable to Microchip Technology	89,909		93,641		86,057		99,402		369,009
Diluted net income per common share attributable to Microchip Technology stockholders	0.40		0.42		0.39		0.45		1.65

Refer to Note 3, Special Charges, for an explanation of the special charges included in operating income in fiscal 2016 and fiscal 2015. Refer to Note 15, 2.125% Junior Subordinated Convertible Debentures, for an explanation of the loss on retirement of convertible debentures of approximately $50.6 million included in net income (loss) during the fourth quarter of fiscal 2015. Refer to Note 4, Investments, for an explanation of the net realized gain from sales of available-for-sale marketable equity securities included in net income during the fourth quarter of fiscal 2015 and the first quarter of fiscal 2016.